Cecilia Linde

ORCID: 0000-0002-9039-6023
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac pacing and defibrillation studies
  • Cardiac Arrhythmias and Treatments
  • Cardiovascular Function and Risk Factors
  • Heart Failure Treatment and Management
  • Cardiac electrophysiology and arrhythmias
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Structural Anomalies and Repair
  • Cardiomyopathy and Myosin Studies
  • Neurological disorders and treatments
  • Cardiac Imaging and Diagnostics
  • Hemodynamic Monitoring and Therapy
  • Potassium and Related Disorders
  • Blood Pressure and Hypertension Studies
  • Heart Rate Variability and Autonomic Control
  • Cardiovascular and exercise physiology
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiovascular Syncope and Autonomic Disorders
  • Advanced MRI Techniques and Applications
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiac Valve Diseases and Treatments
  • Electrolyte and hormonal disorders
  • ECG Monitoring and Analysis
  • Cardiac Health and Mental Health
  • Viral Infections and Immunology Research
  • Erythropoietin and Anemia Treatment

Karolinska Institutet
2016-2025

Karolinska University Hospital
2016-2025

Uppsala University
2022

Stavanger University Hospital
2020

University of Bergen
2019-2020

Institute of Cardiology
2018

Corona (Poland)
2018

Centre Hospitalier Universitaire de Rennes
2008-2017

AstraZeneca (Sweden)
2017

University of Gothenburg
2017

The ESC Guidelines represent the views of and were arrived at after careful consideration available evidence time they written.Health professionals are encouraged to take them fully into account when exercising their clinical judgement.The guidelines do not, however, override individual responsibility health make appropriate decisions in circumstances patients, consultation with that patient and, where necessary, patient's guardian or carer.It is also professional's verify rules regulations...

10.1093/eurheartj/eht150 article EN European Heart Journal 2013-06-24

One third of patients with chronic heart failure have electrocardiographic evidence a major intraventricular conduction delay, which may worsen left ventricular systolic dysfunction through asynchronous contraction. Uncontrolled studies suggest that multisite biventricular pacing improves hemodynamics and well-being by reducing asynchrony. We assessed the clinical efficacy safety this new therapy.

10.1056/nejm200103223441202 article EN New England Journal of Medicine 2001-03-22

Guidelines and Expert Consensus Documents aim to present all the relevant evidence on a particular issue in order help physicians weigh benefits risks of diagnostic or therapeutic procedure.They should be helpful everyday clinical decision-making.A great number have been issued recent years by European Society Cardiology (ESC) different organizations other related societies.This profusion can put at stake authority validity guidelines, which only guaranteed if they developed an...

10.1093/eurheartj/ehi204 article EN European Heart Journal 2005-05-18
Michael Glikson Jens Cosedis Nielsen Mads Brix Kronborg Yoav Michowitz Angelo Auricchio and 95 more Israel Moshe Barbash José A. Barrabés Giuseppe Boriani Frieder Braunschweig Michele Brignole Haran Burri Andrew J.S. Coats Jean‐Claude Deharo Victoria Delgado Gerhard‐Paul Diller Carsten W. Israel Andre Keren Reinoud E. Knops Dipak Kotecha Christophe Leclercq Béla Merkely Christoph Starck Ingela Thylén José Marı́a Tolosana Francisco Leyva Cecilia Linde Magdy Abdelhamid Victor Aboyans Elena Arbelo Riccardo Asteggiano Gonzalo Barón‐Esquivias Johann Bauersachs Mauro Biffi Ulrika Birgersdotter‐Green Maria Grazia Bongiorni Michael A. Borger Jelena Čelutkienė Maja Čikeš Jean‐Claude Daubert Inga Drossart Kenneth A. Ellenbogen Perry Elliott Larissa Fabritz Volkmar Falk Laurent Fauchier Francisco Fernández‐Avilés Dan Foldager Fredrik Gadler Pastora Gallego García de Vinuesa Bülent Görenek María José Guerra Palmero Kristina H. Haugaa Jeroen Hendriks Thomas Kahan Hugo A. Katus А. О. Конради Konstantinos C. Koskinas Hannah Law Basil S. Lewis Nicholas J. Linker Maja‐Lisa Løchen Joost Lumens Julia Mascherbauer Wilfried Müllens Klaudia Vivien Nagy Eva Prescott Pekka Raatikainen Amina Rakisheva Tobias Reichlin Renato Pietro Ricci Е. V. Shlyakhto Marta Sitges Miguel Sousa‐Uva Richard Sutton Piotr Suwalski Jesper Hastrup Svendsen Rhian M. Touyz Isabelle C. Van Gelder Kevin Vernooy Johannes Waltenberger Zachary I. Whinnett Klaus K. Witte Mads Brix Kronborg Yoav Michowitz Angelo Auricchio Israel Moshe Barbash José A. Barrabés Giuseppe Boriani Frieder Braunschweig Michele Brignole Haran Burri Andrew J.S. Coats Jean‐Claude Deharo Victoria Delgado Gerhard‐Paul Diller Carsten W. Israel Andre Keren Reinoud E. Knops Dipak Kotecha Christophe Leclercq

The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy, and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...

10.1093/eurheartj/ehab364 article EN European Heart Journal 2021-08-29

The ESC Guidelines represent the views of and were arrived at after careful consideration available evidence time they written.Health professionals are encouraged to take them fully into account when exercising their clinical judgement.The guidelines do not, however, override individual responsibility health make appropriate decisions in circumstances patients, consultation with that patient and, where necessary, patient's guardian or carer.It is also professional's verify rules regulations...

10.1093/europace/eut206 article EN EP Europace 2013-06-24

Guidelines and Expert Consensus Documents summarize evaluate all currently available evidence on a particular issue with the aim to assist physicians in selecting best management strategies for typical patient, suffering from given condition, taking into account impact outcome, as well risk–benefit ratio of diagnostic or therapeutic means. are no substitutes textbooks. The legal implications medical guidelines have been discussed previously. A great number issued recent years by European...

10.1093/eurheartj/ehm305 article EN European Heart Journal 2007-08-02

The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy, and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...

10.1093/europace/euab232 article EN EP Europace 2021-08-29

One large study, MIRACLE ICD 9 and one meta-analysis 15 support the choice of a CRT-D in patients NYHA class III/IV, with LVEF ≤35%, QRS width ≥120 ms conventional indication for an ICD.Key points † New: LV dilatation no longer required recommendation.† IV should be ambulatory.† reasonable expectation survival good functional status .1 year CRT-D.† Evidence is strongest typical LBBB.† Similar level evidence CRT-P CRT-D.

10.1093/europace/euq392 article EN EP Europace 2010-10-25

The Committee for Practice Guidelines (CPG) of the European Society Cardiology recognizes that new evidence from clinical research trials may impact on current recommendations. heart failure (HF) guidelines1 were published in 2008 and cardiac pacing guidelines 2007.2 In order to keep these up date, it would be appropriate modify recommendations levels according most recent trial evidence. This Focused Update use devices 2010 is first publication its kind CPG. Practice Guideline should...

10.1093/eurheartj/ehq337 article EN European Heart Journal 2010-08-27

Niniejsze wytyczne ESC opublikowano wyłącznie do użytku prywatnego i edukacyjnego.Nie zezwala się na wykorzystywanie w celach komercyjnych.Żadna część wytycznych nie może być tłumaczona ani kopiowana żadnej postaci bez wcześniejszej pisemnej zgody ESC.Pozwolenie można uzyskać, zwracając

10.5603/kp.2016.0141 article PL Kardiologia Polska 2016-10-13

Background— Cardiac resynchronization therapy (CRT) decreases mortality, improves functional status, and induces reverse left ventricular remodeling in selected populations with heart failure. We aimed to assess the impact of baseline QRS duration morphology change pacing on CRT outcomes mild Methods Results— Resynchronization Reverses Remodeling Systolic Left Ventricular Dysfunction (REVERSE) was a multicenter randomized trial among 610 patients Baseline CRT-paced durations were evaluated...

10.1161/circulationaha.112.097709 article EN Circulation 2012-07-11
Coming Soon ...